Sector portfolio · VC firm · United Kingdom

IP Group's Biotech portfolio

IP Group has backed 19 Biotech startups in rounds we track, $921M between them, shown by the stage each has reached. The best-funded is Oxford Nanopore Technologies.

19startups backed
5stages
$921Mraised between them
Pre-seed and seedbiggest stage

IP Group's whole portfolioIP Group's profile

Pre-seed and seed

5

Series A

4

Stage not reported

4

Series C and later

3

Series B

3

Segment by segment

Pre-seed and seed

5 startups · $13M raised

  1. Kynos TherapeuticsKynos Therapeutics develops KMO inhibitors across key indications in inflammation, immunity, and metabolism.United Kingdom$8.5M
  2. Resseptor TherapeuticsCovalent-binding TCRs for autoimmune & oncologyAustralia$1.5M
  3. Jetra TherapeuticsJetra Therapeutics is a preclinical biotechnology company developing a novel engineered protein for the treatment of obesity-relatAustralia$1.3M
  4. AmprologixAmprologix is a UK biotechnology company based in Plymouth, England, founded in 2018.United Kingdom$992K
  5. UbiquigentUbiquigent provides the research community with reagents, kits, and drug discovery, assay development and compound profiling services.United Kingdom$758K

Series A

4 startups · $92M raised

  1. InnervaceInnervace is a regenerative medicine company focused on developing implantable tissue-engineered neural pathways to restore brain United States$40M
  2. Rage BiotechRAGE Biotech is a biotechnology industry.Australia$29M
  3. Kira BiotechKira Biotech is an Immunology Company.Australia$20M
  4. Clyde BiosciencesClyde Biosciences Limited is a leading provider of cardiac cell analysis and safety services, specializing in cardiomyocyte safetyUnited Kingdom$2.9M

Stage not reported

4 startups · $146M raised

  1. MISSION TherapeuticsMission Therapeutics is a clinical-stage biopharmaceutical company based in Cambridge, UK, focused on drug discovery and developmeUnited Kingdom$113M
  2. IstessoIstesso is a London-based biopharmaceutical company focused on immunometabolism drug discovery and development.United Kingdom$29M
  3. SpireaSpirea Ltd.United Kingdom$3.4M
  4. AActiviomicsActiviomics develops phosphoproteomics solutions for biomarker discovery and drug candidate profiling.United Kingdom$805K

Series C and later

3 startups · $524M raised

  1. STORM TherapeuticsTargeting pathways that modify RNA to deliver novel cancer therapeuticsUnited Kingdom$317M
  2. MicrobioticaMicrobiotica is a clinical-stage biopharmaceutical company based in Cambridge, UK, founded in 2016.United Kingdom$117M
  3. Carisma TherapeuticsCarisma Therapeutics is a biotech company that develops novel chimeric antigen receptor macrophage technology to treat solid tumors.United States$90M

Series B

3 startups · $145M raised

  1. ArtiosArtios Pharma Limited is a privately held biotechnology company based in Cambridge, United Kingdom, at the Babraham Research Campus.United Kingdom$83M
  2. IInivataUnited Kingdom$59M
  3. OOxyntixOxyntix is a research-intensive team, developing and commercialising new technologies in energy and process engineering, among other fields.United Kingdom$2.6M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names IP Group as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Portfolio mapIP Group portfolio map67 startups · $3.4BCo-investorsWho invests with IP Group32 co-investorsSector portfolioAntler's AI portfolio168 startups · $3.8BSector portfolioIndex Ventures' AI portfolio126 startups · $49BSector portfolioInnovate UK's Biotech portfolio88 startups · $1.7BSector portfolioGSR's Web3 & Crypto portfolio77 startups · $4.2B

Raising from investors like IP Group?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps